Ketamine Long Therm Follow Up Study

Ketamine

Brief Summary

Results of the study and of 5 years follow up of depressed patients who participated in the study during 2014-2015. We will locate the participants and will interview them will use the same questionnaires to evaluate their depressive symptoms. We will also measure the time to relapse.

Intervention / Treatment

Condition or Disease

Followin Ketamine Treatment

Phase

Study Design

Study type:	OBSERVATIONAL
Status:	Unknown status
Study results:	No Results Available
Age:	up to 90 Years (Child, Adult, Older Adult)
Enrollment:	16 (ESTIMATED)
Funded by:	Other
Time Perspective:	Prospective
Observational Model:	Cohort
Masking

Clinical Trial Dates

Start date:	Dec 14, 2019	ACTUAL
Primary Completion:	Feb 01, 2020	ESTIMATED
Completion Date:	Apr 01, 2020	ESTIMATED
Study First Posted:	Jan 23, 2020	ACTUAL
Results First Posted:	Aug 31, 2020
Last Updated:	Jan 18, 2020

Sponsors / Collaborators

Lead Sponsor: The Chaim Sheba Medical Center

Responsible Party: N/A

Location

RI, Israel

Ramat Gan, RI, Israel

Anamnestic data will be collected from the patients, in addition, depressive symptoms will be measured using Montgomery Asberg Depression Scale (MADRAS). In addition, the Clinical Global Severity Scale (CGI-S) and Clinical Global Improvement (CGI-I) were performed 2 hours after treatment. In addition, we performed to prolong the time to relapse in this patient.

Eligibility Criteria

Sex:	All
Maximum Age:	90
Age Groups:	Child / Adult / Older Adult
Healthy Volunteers:	Yes

Inclusion Criteria:

* Participants in the ketamine study

Exclusion Criteria:

-

Primary Outcomes

Medications

More Details

NCT Number:	NCT04238039
Acronym:	ket_Fol_Up
Other IDs:	5826-18-SMC
Study URL:	https://clinicaltrials.gov/study/NCT04238039

Last updated: Sep 29, 2023